Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 709 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Australia receives first shipment of Altrazeal

Altrazeal, a wound treatment technology, has shown clinical and economic advantages in a number of chronic and acute wounds, which include diabetic foot ulcers, venous leg ulcers and

Idenix, Novartis revise collaboration agreement

As part of the revised agreement, Novartis’ optional right to license Idenix’s current and future development-stage drug candidates in any therapeutic area has terminated while it enjoys non-exclusive

Adimab, Mersana partner on ADC technologies

The partnership will provide pharmaceutical companies an access to Adimab’s antibodies, which have been specifically optimized for use in ADCs together with Mersana’s Fleximer polymer and array of

InSite Vision begins BromSite Phase 3 Study

The study will enroll nearly 240 cataract surgery patients in a two-arm trial, which is designed to evaluate the efficacy and safety of BromSite against the DuraSite vehicle